Patent intelligence · US
US 2011178580
ENHANCED ANTI-MICROBIAL PDT
ENHANCED ANTI-MICROBIAL PDT
Patent details — US 2011178580
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jul 21, 2011
- Expiration
- Jul 16, 2031
- Applicant
- ALBRECHT VOLKER [DE]
- CPC classes
- A61P/3104
Quick answer
US 2011178580 (ENHANCED ANTI-MICROBIAL PDT) is held by ALBRECHT VOLKER [DE]. Status: granted. Granted Jul 21, 2011. Expires Jul 16, 2031 (5 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- ALBRECHT VOLKER [DE]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61P/3104
More from ALBRECHT VOLKER [DE]
Related pharmaceutical patents in our USPTO index.
-
BR PI0714667
conjugado molecular e respectivo uso
granted -
MX 2013000877
APPLICATION OF β-FUNCTIONALIZED DIHYDROXY-CHLORINS FOR PDT.
granted -
US 2013041307
APPLICATION OF BETA-FUNCTIONALIZED DIHYDROXY-CHLORINS FOR PDT
granted -
WO 2013015774
DIHYDROXY-CHLORINES GLYCO-SUBSTITUÉES ET CHLORINES BÊTA-FONCTIONNALISÉES POUR THÉRAPIE ANTIMICROBIENNE PHOTODYNAMIQUE
granted -
BR PI0614453
método de redução de cululite indesejada em áreas seletivas de um organismo e mistura fotossensibilizante
granted -
US 2012263625
GLYCO-SUBSTITUTED DIHYDROXY-CHLORINS AND ß-FUNCTIONALIZED CHLORINS FOR ANTI-MICROBIAL PHOTODYNAMIC THERAPY
granted -
US 2012259187
DYNAMIC COLORECTAL PDT APPLICATION
granted -
US 2011206613
METHOD AND APPLICATION OF UNSYMMETRICALLY meso-SUBSTITUTED PORPHYRINS AND CHLORINS FOR PDT
granted
Frequently asked questions
What is US patent 2011178580?
US 2011178580 (ENHANCED ANTI-MICROBIAL PDT) is held by ALBRECHT VOLKER [DE]. Status: granted. Granted Jul 21, 2011. Expires Jul 16, 2031 (5 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 2011178580?
ALBRECHT VOLKER [DE] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does US 2011178580 expire?
Our index shows an expiration date of Jul 16, 2031 (5 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.